Yanni, John M.,Chatterton, Jon E.,Gamache, Daniel A.,Miller, Steven T.
申请号：
AU2013207601
公开号：
AU2013207601B2
申请日:
2013.07.17
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
#$%^&*AU2013207601B220161117.pdf#####ABSTRACT RNA interference is provided for inhibition of spleen tyrosine kinase (Syk) mRNA expression, in particular, for treating patients having a Syk-related inflammatory condition or at risk of developing a Syk-related inflammatory condition such as allergic conjunctivitis, ocular inflammation, dermatitis, rhinitis, asthma, allergy, or mast-cell disease.
